Juncture Wealth Strategies LLC cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 1.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,258 shares of the biotechnology company’s stock after selling 44 shares during the quarter. Axon Enterprise comprises about 0.9% of Juncture Wealth Strategies LLC’s holdings, making the stock its 18th biggest holding. Juncture Wealth Strategies LLC’s holdings in Axon Enterprise were worth $2,531,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Public Sector Pension Investment Board raised its stake in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after buying an additional 500 shares in the last quarter. CIBC Asset Management Inc raised its position in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after acquiring an additional 895 shares in the last quarter. Foundations Investment Advisors LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at approximately $221,000. Sequoia Financial Advisors LLC boosted its position in shares of Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after purchasing an additional 81 shares in the last quarter. Finally, Axxcess Wealth Management LLC purchased a new stake in Axon Enterprise in the third quarter worth $814,000. 79.08% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts have commented on the company. The Goldman Sachs Group raised their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. JMP Securities lifted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $504.92.
Axon Enterprise Trading Down 0.5 %
AXON stock opened at $610.32 on Friday. The firm has a fifty day moving average price of $617.65 and a 200 day moving average price of $470.75. Axon Enterprise, Inc. has a fifty-two week low of $247.04 and a fifty-two week high of $698.67. The firm has a market cap of $46.54 billion, a PE ratio of 157.71, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
Insider Buying and Selling at Axon Enterprise
In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 over the last 90 days. 6.10% of the stock is owned by insiders.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
- Five stocks we like better than Axon Enterprise
- Options Trading – Understanding Strike Price
- Bloom Energy: Powering the Future With Decentralized Energy
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- ETF Screener: Uses and Step-by-Step Guide
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.